F. Gilbert Bickel
Direttore/Membro del Consiglio presso St. Louis Regional Chamber & Growth Association
Profilo
F.
Gilbert Bickel is currently a Director at St. Louis Regional Chamber & Growth Association.
Prior to this, he was a Director at Sequoia Vaccines, Inc.
Posizioni attive di F. Gilbert Bickel
| Società | Posizione | Inizio |
|---|---|---|
St. Louis Regional Chamber & Growth Association
 St. Louis Regional Chamber & Growth Association Miscellaneous Commercial ServicesCommercial Services St. Louis Regional Chamber & Growth Association operates as a non-profit organization, which engages in economic development business and public policy. The company was founded in 1836 and is headquartered in St. Louis, MO. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di F. Gilbert Bickel
| Società | Posizione | Fine |
|---|---|---|
Sequoia Vaccines, Inc.
 Sequoia Vaccines, Inc. BiotechnologyHealth Technology Sequoia Vaccines, Inc. is a clinical stage pharmaceutical company engages in developing vaccine to prevent recurrent urinary tract infections and small molecules treating cancers and bacterial infections. The company was founded by Gary Eldridge in 2012 and is headquartered in St. Louis, MO. | Direttore/Membro del Consiglio | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
St. Louis Regional Chamber & Growth Association
St. Louis Regional Chamber & Growth Association Miscellaneous Commercial ServicesCommercial Services St. Louis Regional Chamber & Growth Association operates as a non-profit organization, which engages in economic development business and public policy. The company was founded in 1836 and is headquartered in St. Louis, MO. | Commercial Services |
Sequoia Vaccines, Inc.
Sequoia Vaccines, Inc. BiotechnologyHealth Technology Sequoia Vaccines, Inc. is a clinical stage pharmaceutical company engages in developing vaccine to prevent recurrent urinary tract infections and small molecules treating cancers and bacterial infections. The company was founded by Gary Eldridge in 2012 and is headquartered in St. Louis, MO. | Health Technology |
- Borsa valori
- Insiders
- F. Gilbert Bickel
